Jean‐Philippe Arnault

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà et al. · The Lancet Oncology · 2021 · 389 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort

Sarah Faiz, Jonathan Giovannelli, Céline Podevin et al. · Journal of the American Academy of Dermatology · 2019 · 207 citations · Full text

Life Sciences, Dermatology, Immunology +8

Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas

E. Maubec, Marouane Boubaya, Peter Petrow et al. · Journal of Clinical Oncology · 2020 · 174 citations

Medicine, Oncology, Pharmacology +16

Prognostic Factors of Paraneoplastic Pemphigus

Sandy Léger, D Picard, S. Oro et al. · Archives of Dermatology · 2012 · 151 citations

Medicine, Dermatology, Oncology +17

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma

C. Mignard, Aurélie Deschamps Huvier, André Gillibert et al. · Journal of Oncology · 2018 · 82 citations · Full text

Medicine, Dermatology, Oncology +17